US Patent Issued to ASCENDIS PHARMA GROWTH DISORDERS on Aug. 5 for "Dry pharmaceutical formulations of CNP conjugates" (Danish, German Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,133, issued on Aug. 5, was assigned to ASCENDIS PHARMA GROWTH DISORDERS A/S (Hellerup, Denmark).

"Dry pharmaceutical formulations of CNP conjugates" was invented by Anja R. H. Skands (Hellerup, Denmark), Ulrich Hersel (Heidelberg, Germany), Charlotte Pinholt (Hellerup, Denmark) and Stefan Heinig (Heidelberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A dry pharmaceutical formulation, wherein the pharmaceutical formulation comprises a CNP conjugate, a buffering agent and a bulking agent and wherein the CNP conjugate comprises a CNP moiety that is covalently and reversibly conjugated to a polymeric moiety."

The patent was filed on Feb. 10,...